Jan-04-21 03:11PM | |
11:00AM | |
Dec-31-20 04:21PM | |
12:47PM | |
Dec-23-20 12:40AM | |
Dec-20-20 12:05AM | |
Dec-16-20 04:42PM | |
Dec-14-20 09:28AM | |
02:39AM | |
Dec-12-20 08:13PM | |
Dec-10-20 09:10PM | |
Dec-09-20 11:30PM | |
Dec-07-20 08:22PM | |
Dec-05-20 09:20PM | |
Nov-30-20 08:55PM | |
08:49PM | |
07:15AM | |
Nov-29-20 07:45AM | |
Nov-26-20 09:14AM | |
Nov-25-20 11:10PM | |
07:35AM | |
07:00AM | |
Nov-24-20 08:12AM | |
Nov-22-20 07:22AM | |
Nov-18-20 04:01PM | |
Nov-16-20 07:15AM | |
Nov-12-20 10:06AM | |
Nov-09-20 07:15AM | |
06:15AM | |
Nov-02-20 07:15AM | |
Oct-30-20 08:40PM | |
04:15PM | |
Oct-19-20 02:50PM | |
08:30AM | |
Oct-14-20 09:25AM | |
Oct-05-20 07:15AM | |
Sep-17-20 07:15AM | |
Sep-14-20 01:04PM | |
Aug-28-20 07:15AM | |
Aug-20-20 09:15AM | |
Aug-10-20 07:15AM | |
Aug-05-20 05:30PM | |
07:15AM | |
Aug-03-20 09:20AM | |
Jul-24-20 09:08AM | |
Jul-08-20 10:35PM | |
Jul-02-20 04:01PM | |
Jun-30-20 07:41AM | |
Jun-29-20 10:45PM | |
10:30PM | |
04:05PM | |
04:01PM | |
Jun-16-20 08:20AM | |
Jun-12-20 07:09PM | |
Jun-05-20 03:30PM | |
May-29-20 10:31AM | |
May-27-20 08:04PM | |
May-22-20 10:01AM | |
May-18-20 07:15AM | |
May-11-20 04:01PM | |
May-07-20 09:30AM | |
May-06-20 06:30PM | |
Apr-30-20 07:30AM | |
Apr-09-20 07:30AM | |
Apr-08-20 07:45AM | |
Mar-11-20 08:15AM | |
07:00AM | |
Mar-04-20 12:30PM | |
Feb-26-20 04:30PM | |
04:30PM | |
Jan-27-20 02:55PM | American City Business Journals -8.13% |
08:00AM | |
Jan-24-20 09:00AM | |
Jan-15-20 07:29AM | |
Dec-26-19 02:55PM | American City Business Journals +43.47% |
10:32AM | |
Dec-24-19 08:30AM | |
Dec-20-19 06:21PM | |
Nov-13-19 08:15AM | |
07:00AM | |
06:00AM | |
Nov-06-19 08:00AM | |
Nov-01-19 08:00AM | |
Oct-23-19 10:33AM | |
Oct-22-19 10:52AM | |
Sep-25-19 04:05PM | |
Sep-12-19 04:05PM | |
Sep-03-19 07:00AM | |
Aug-27-19 02:44PM | American City Business Journals -17.57% |
Aug-08-19 04:05PM | |
07:00AM | |
Aug-02-19 09:00AM | |
Jul-24-19 01:01PM | |
Jun-28-19 08:35PM | |
02:17PM | American City Business Journals |
Jun-26-19 04:15PM | |
Jun-05-19 04:05PM | |
Jun-03-19 08:30AM | |
May-22-19 04:30PM | |
May-14-19 04:15PM | |
|
|
|
Liquidia Corporation, through its subsidiaries, operates as a late-stage clinical biopharmaceutical company. The company focuses on the development and commercialization of various products using its PRINT technology that enables precise production of drug particles designed to enhance the safety, efficacy, and performance of a range of therapies. Its product candidates include LIQ861 for the treatment of pulmonary arterial hypertension; and LIQ865 for the treatment of local post-operative pain. The company also provides strategy, investment, and commercialization services for rare disease pharmaceutical products, such as generic Remodulin, a parenteral formulation of treprostinil for pulmonary arterial hypertension. Liquidia Corporation was founded in 2004 and is based in Morrisville, North Carolina. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Eshelman Ventures, LLC | 10% Owner | Jan 14 | Sale | 3.02 | 34,466 | 103,918 | 6,085,149 | Jan 15 05:44 PM | Eshelman Ventures, LLC | 10% Owner | Jan 13 | Sale | 3.07 | 3,393 | 10,416 | 6,119,615 | Jan 15 05:44 PM | Eshelman Ventures, LLC | 10% Owner | Jan 12 | Sale | 3.06 | 99,335 | 304,402 | 6,123,008 | Jan 13 06:00 PM | Eshelman Ventures, LLC | 10% Owner | Jan 11 | Sale | 3.05 | 13,524 | 41,250 | 6,222,343 | Jan 13 06:00 PM | Eshelman Ventures, LLC | 10% Owner | Jan 08 | Sale | 3.08 | 71,902 | 221,508 | 6,235,867 | Jan 11 05:50 PM | Eshelman Ventures, LLC | 10% Owner | Jan 07 | Sale | 3.12 | 142,819 | 445,638 | 6,307,769 | Jan 11 05:50 PM | Eshelman Ventures, LLC | 10% Owner | Dec 22 | Sale | 3.14 | 7,949 | 24,960 | 6,450,588 | Dec 28 05:20 PM | Eshelman Ventures, LLC | 10% Owner | Dec 21 | Sale | 3.13 | 51,906 | 162,466 | 6,458,537 | Dec 22 07:08 PM | Eshelman Ventures, LLC | 10% Owner | Dec 18 | Sale | 3.14 | 53,309 | 167,470 | 6,510,443 | Dec 22 07:08 PM | Eshelman Ventures, LLC | 10% Owner | Dec 14 | Sale | 3.13 | 6,417 | 20,085 | 6,563,752 | Dec 16 05:11 PM | Eshelman Ventures, LLC | 10% Owner | Nov 30 | Sale | 3.13 | 200 | 626 | 6,570,169 | Dec 01 08:56 PM | Eshelman Ventures, LLC | 10% Owner | Nov 27 | Sale | 3.13 | 200 | 626 | 6,570,369 | Dec 01 08:56 PM | Eshelman Ventures, LLC | 10% Owner | Nov 25 | Sale | 3.13 | 17,364 | 54,349 | 6,570,569 | Dec 01 08:34 PM | Eshelman Ventures, LLC | 10% Owner | Nov 24 | Sale | 3.15 | 283,465 | 894,247 | 6,587,933 | Dec 01 08:34 PM | Eshelman Ventures, LLC | 10% Owner | Nov 23 | Sale | 3.16 | 133,346 | 421,347 | 6,871,398 | Dec 01 08:34 PM | Eshelman Ventures, LLC | 10% Owner | Nov 19 | Sale | 3.35 | 30,000 | 100,500 | 7,004,744 | Dec 01 08:34 PM | Eshelman Ventures, LLC | 10% Owner | Jul 02 | Buy | 8.00 | 1,875,000 | 15,000,000 | 7,034,744 | Jul 02 07:31 PM | Maynor Benjamin | SVP, Research and Development | May 27 | Option Exercise | 2.69 | 4,754 | 12,788 | 11,735 | May 28 04:30 PM | Maynor Benjamin | SVP, Research and Development | Apr 14 | Option Exercise | 1.85 | 6,132 | 11,344 | 10,300 | Apr 16 04:30 PM | Eshelman Ventures, LLC | 10% Owner | Apr 06 | Buy | 5.28 | 44,250 | 233,715 | 175,573 | Apr 07 05:18 PM | Eshelman Ventures, LLC | 10% Owner | Apr 03 | Buy | 4.85 | 35,000 | 169,740 | 131,323 | Apr 07 05:18 PM | Eshelman Ventures, LLC | 10% Owner | Apr 02 | Buy | 4.96 | 7,223 | 35,792 | 96,323 | Apr 03 05:40 PM | Eshelman Ventures, LLC | 10% Owner | Apr 01 | Buy | 4.89 | 45,000 | 220,122 | 89,100 | Apr 03 05:40 PM | Eshelman Ventures, LLC | 10% Owner | Mar 31 | Buy | 4.87 | 30,000 | 146,112 | 44,100 | Apr 01 05:35 PM | Eshelman Ventures, LLC | 10% Owner | Mar 30 | Buy | 4.76 | 14,100 | 67,106 | 14,100 | Apr 01 05:35 PM |
|